메뉴 건너뛰기




Volumn 22, Issue 1, 2002, Pages 93-94

Incompatiblity of vancomycin and ceftazidime for intraperitoneal use [5]

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CEFTAZIDIME ARGININE; VANCOMYCIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

EID: 0036010550     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080202200120     Document Type: Letter
Times cited : (5)

References (11)
  • 2
    • 0027207898 scopus 로고
    • Physical incompatibility of vancomycin and ceftazidime for intravitreal injection
    • (Letter)
    • (1993) Arch. Ophthalmol , vol.111 , pp. 730
    • Fiscella, R.G.1
  • 7
    • 0003700389 scopus 로고    scopus 로고
    • AHFS drug information
    • ed Bethesda, MD: American Society of Health-System Pharmacists
    • (1999)
    • McEvoy, G.K.1
  • 8
    • 0008813569 scopus 로고    scopus 로고
    • GlaxoSmithKline. Ceptaz (ceftazidime L-arginine formulation) package insert. Research Triangle Park, NC: GlaxoSmithKline
    • (1998)
  • 10
    • 0028205014 scopus 로고
    • Stability of ceftazidime and vancomycin alone and in combination in heparinized and nonheparinized peritoneal dialysis solution
    • (1994) Ann. Pharmacother , vol.28 , pp. 572-576
    • Vaughan, L.M.1    Poon, C.Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.